Nimodipine does not increase cerebral blood flow during subarachnoid hemorrhage in the rat

Pharmacology

Volumn 53, Issue 1, 1996, Pages 1-10

  Watanabe, Hiroshi ^a   Clozel, Martine ^a   Clozel, Jean Paul ^a  

^a Department of Toxicology   (Japan)

Author keywords

Calcium antagonist; Cerebral blood flow; Nimodipine; Rats; Subarachnoid hemorrhage

Indexed keywords

CALCIUM ANTAGONIST; MICROSPHERE; NIMODIPINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE;

EID: 0029792606     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139409     Document Type: Article

References (36)

1. Langley MS, Sorkin EM: Nimodi-pinc: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease, Drugs 1989: 37:669-699.
2. McCalden TA, Nath RG, Thiele K: The effects of a calcium antagonist (nimodipine) on basal cerebral blood flow and reactivity to various agonists, Stroke 1984;15:527-530.
3. Mohamed AA, Mendelow AD, Teasdale GM, Harper AM, McCulloch J: Effect of the calcium antagonist nimodipine on local cerebral blood flow and metabolic coupling, J Ccreb Blood Flow Metab 1985:5: 26-33.
4. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys, J Neurosurg 1984:60: 1167-1175.
5. Lewis PJ, Weir BKA, Nosko MG, Tanabc T, Grace MG: Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm, Ncurosurgcrv 1988:22:492-500.
6. Nosko M, Weir B, Krueger C, Cook D, Norris S, Overton T, Boisvert T: Nimodipine and chronic vasospasm in monkeys, I, Clinical and radiological findings, Neurosurgery 1985; 16:129-136.
7. Gioia AE, White RP, Bakhtian B, Robertson JT: Evaluation of the efficacy of intrathecal nimodipine in canine model of chronic cerebral vasospasm, J Neurosurg 1985:62:721-728.
8. Sahlin C, Delgado T, Owman C, Svcndgaard NA: Changes in cerebral blood flow and metabolism following intraarterial or local administration of nimodipine, before and after experimental subarachnoid hemorrhage in baboons, Stroke 1986:17:220-224.
9. Petruk KC, West M, Mohr G, et al: Nimodipine treatment in poor-grade aneurysm patients, Results of a multiccntcr double-blind placebo-controlled trial, J Neurosurg 1988: 68:505-517.
10. Pickard JD, Murray GD, Illingworth R, Shaw MDM, Teasdale GM, Foy PM, Humphrey PRD, Lang DA, Nelson R, Richards P, Sinar J, Baily S, Skene A: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage, British Aneurysm Nimodipine Trial, Br Med J 1989:298:636-642.
11. Robinson MJ, Teasdale GM: Calcium antagonists in the management of subarachnoid haemorrhage, Ccrcbrovasc Brain Metab Rev 1990: 2:205-226.
12. Alien GS, Ahn I IS, Prcziosi TJ, Bat-lye R, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert PJ, Hindley MB, Johnson RK, Strom JA, Transou CR: Cerebral arterial spasm: A controlled trial of nimodipine in patients with subarachnoid hemorrhage, N Engl J Med 1983;308:619-624.
13. Mce E, Dorrance D, Lowe D, Neil-Dwycr G: Controlled study of nimodipine in aneurysm patients treated early after subarachnoid haemorrhage, Neurosurgery 1988; 22:484-491.
14. Flaim SF, Nellis SH, Toggart EJ, Drexler H, Kanda K, Newman ED: Multiple simultaneous determinations of hemodynamics and flow distribution in conscious rats, J Pharmacol Methods 1984; 11:1-39.
15. Solomon RA, Antunes JL, Chen RY, Bland L, Chien S: Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: A new animal model, Stroke 1985;16:58-64.
16. Delgado TJ, Brismar J, Svengaard NA: Subarachnoid haemorrhage in the rats: Angiography and fluorescence microscopy of the major cerebral arteries, Stroke 1985; 16:595-601.
17. Jackowski A, Crockard A, Bum-stock G, Ross Russel R, Kristek F: The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat, J Cereb Blood Flow Metab 1990:10:835-849.
18. Solomon RA, Lovitz RI, Hegemann MT, Schucsslcr GB, Young WL, Chien S: Regional cerebral metabolic activity in the rat following experimental subarachnoid hemorrhage, J Cereb Blood Flow Metab 1987:7: 193-198.
19. Svengaard NA, Brismar J, Delgado JT, Rosengren E: Subarachnoid haemorrhage in the rats: Effect on the development of vasospasm of selective lesions of the catecholamine system in the lower brain stem, Stroke 1985:16:602-608.
20. Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm, Stroke 1991;22:971-982.
21. Toda N, Kawakami M, Yoshida K: Constrictor action of oxyhemoglobin in monkey and dog basilar arteries in vivo and vitro, Am J Physiol 1991;260:H420-H425.
22. Findlay JM, Macdonald RL, Weir BKA: Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage, Ce-rebrovasc Brain Mctab Rev 1991:3: 336-361.
23. Somlyo AP, Himpcns B: Cell calcium and its regulation in smooth muscle, FASEB J 1985:3:2266-2276.
24. Kanda K, Flaim SF: Effect of ni-modipine on cerebral flow in conscious rats, J Pharmacol Exp Ther 1985;236:41-47.
25. Grabowski M, Johansson BB: Nifedipine and nimodipine: Effect on blood pressure and regional blood flow in conscious normotensive and hypertensive rats, J Cardiovasc Pharmacol 1985:7:1127-1133.
26. Teasdale G, Mendelow AD, Graham DJ, Harper AM, McCulloch J: Efficacy of nimodipine in cerebral ischemia or hemorrhage, Stroke 1990;21:IV123-IV125.
27. Young WL, Chien S: Effect of nimodipine on cerebral blood flow and metabolism in rats during hyperventilation, Stroke 1989:20:275-280.
28. Marinov M, Wassmann J, Natschcv S: Effect of nimodipine in treatment of experimental focal cerebral ischemia, Neurol Res 1991;73:77-83.
29. Tanaka K, Gotoh F, Muramatsu F, Fukuuchi Y, Okayasu H, Suzuki N, Kobari M: Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats, Arzneimittel-Forsch 1982;32:1529-1534.
30. Miller RJ: Multiple calcium channels and neuronal function, Science 1987:235:46-52.
31. Nuglisch J, Karkoutly C, Mcnnel HD, Rossberg C, Kricglstein J: Protective effect of nimodipine against ischemic neuronal damage in rat hippocampus without changing postischemic cerebral blood flow, J Cercb Blood Flow Metab 1990:10: 654-659.
32. Berger L, Hakim AM: Nimodipine prevents hvperglycemia-induccd cerebral acidosis in middle cerebral artery occluded rats, J Cercb Blood Flow Metab 1989:9:58-64.
33. Clozel M, Watanabe H: BQ-123 a peptidic endothelin antagonist prevents the early vasospasm following haemorrhage after inlracistemal but not intravenous injection, Life Sci 1993;52:825-834.
34. Suzuki R, Masaoka H, Hirata, Y, Marumo F, Isotani E, Hirakawa K: The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid haemorrhage., J Neurosurg 1992:77:96-103.
35. Roux S, Ioefiler BM, Gray GA, Sprecher U, Clozel M, Clozel JP: The role of endothelin in experimental cerebral vasospasm, Neurosurgery 1995; in press.
36. Clozel M, Shigcno T, Sakai S, Saito A, Goto K: The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm, Neurosurgery 1995; in press.